China investigation of drug firm exec deals latest blow to foreign business confidence

SCMP | Oct. 31, 2024, 9:26 a.m. | Original
Investigation of AstraZeneca’s China president prompts industry calls for more transparency; ‘this is only going to get worse’.
From Zhu Rongji to Wang Qishan, reins pass at a back channel of Chinese diplomacy China’s central bank holds steady with 200 billion yuan net bond purchase